Genetic risk tests come to Canada through WarnexAn exclusive distribution agreement for 10 of deCODE Genetics' DNA-based tests has been signed by Warnex Medical Laboratories, a division of Warnex Inc. of Laval, Que. The tests are designed to assess the risk of developing certain common diseases. Avoidable needle stick injuries persist despite technological advances, safety guidelines New oral contraceptive effective, but not yet approved Women taking nomegestrol-based product had fewer bleeding withdrawal days than those using drospirenone-based pill Nova Scotia pledges help in opioid-abuse problem Working group recommends raft of changes, including better training, information-sharing and disposal of drugs Risk of miscarriage rises with use of certain NSAIDs Quebec researchers’ suggestion of causal relationship draws criticism from head of Motherisk program Counselling affects choice of birth control method Many women switched contraceptive approach when health-care providers took time to explain pros and cons Temporary ER staff make more medication errors Study suggests non-permanent workers in other departments may also need attention Newfoundland and Labrador independents begin legal challenge of Pharmacy Act Group challenging government on two counts. Trajenta: third DDP-4 inhibitor for type 2 diabetes Drug indicated for improving glycemic control in adults with type 2 diabetes. Tech Talk Update Winnipeg technician conference a resounding success. First Previous 1030 1031 1032 1033 1034 Next Last
